These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632 [TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Broekman ML; Comer LA; Hyman BT; Sena-Esteves M Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198 [TBL] [Abstract][Full Text] [Related]
9. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791 [TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency. Hacker UT; Wingenfeld L; Kofler DM; Schuhmann NK; Lutz S; Herold T; King SB; Gerner FM; Perabo L; Rabinowitz J; McCarty DM; Samulski RJ; Hallek M; Büning H J Gene Med; 2005 Nov; 7(11):1429-38. PubMed ID: 15945124 [TBL] [Abstract][Full Text] [Related]
11. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988 [TBL] [Abstract][Full Text] [Related]
12. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction. Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587 [TBL] [Abstract][Full Text] [Related]
13. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice. Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164 [TBL] [Abstract][Full Text] [Related]
14. Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma. Shi W; Hemminki A; Bartlett JS Gynecol Oncol; 2006 Dec; 103(3):1054-62. PubMed ID: 16870238 [TBL] [Abstract][Full Text] [Related]
15. AAV display--homing in on the target. Lieber A Nat Biotechnol; 2003 Sep; 21(9):1011-3. PubMed ID: 12949562 [No Abstract] [Full Text] [Related]
16. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147 [TBL] [Abstract][Full Text] [Related]
18. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Halbert CL; Allen JM; Miller AD Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554 [TBL] [Abstract][Full Text] [Related]
19. A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo. Nitta Y; Kawamoto S; Halbert C; Iwata A; Miller AD; Miyazaki J; Allen MD J Gene Med; 2005 Oct; 7(10):1348-55. PubMed ID: 15945122 [TBL] [Abstract][Full Text] [Related]
20. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Campos SK; Barry MA Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]